Aerska
PrivateLast Round
Series A
May 20, 2026
Total Funding Raised
$119M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aerska is a biotechnology company developing RNA interference (RNAi) medicines designed to treat, delay, and prevent diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aerska Comparables
Compare Aerska with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cenos Therapeutics | 87% | |
| CereCura Nanotherapeutics | 80% | |
| Qinotto, Inc. | 79% |
Aerska Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 20, 2026 | ||||
| Series A | Feb 9, 2026 | ||||
| Seed | Oct 2, 2025 |
Aerska Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A |
| Backed VC | Seed |
| Saras Capital | Seed |
| Lingotto | Seed |
| BlueYard Capital | Seed |
| Ada Ventures | Seed |
| age1 | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 27% QoQ, from 22 to 28 employees.
- Jun 25, 2026
Grew 35% QoQ, from 20 to 27 employees.
Recent news
Latest coverage and updates
- hiresSep 17, 2026
Aerska, Inc. hired Laura Sepp-Lorenzino as Scientific Advisory Board on Sep 17th '26.
Aerska Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aerska's valuation, stock price, and market status.
Is Aerska a public or private company?
Aerska is a private company.
What is the current stock price of Aerska?
Aerska is a private company with no public stock price. No recent secondary market data is available.
How much is Aerska worth (valuation)?
Valuation information for Aerska is not publicly available.
Can I buy Aerska stock?
Aerska shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aerska's last funding round?
Aerska's most recent funding round was Series A on February 9, 2026.
Who are the main investors in Aerska?
Key investors in Aerska include Backed VC, age1, Speedinvest, LSP Dementia Fund.
Will Aerska IPO soon?
No public IPO plans have been announced for Aerska.
How can I track Aerska secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aerska's secondary market activity and sign up for updates.